The products of “ATM Pharm” Company
The Company “ATM Partners”has acquired to its assortment portfolio the products of “ATM Pharm” Company. It is a number of new generation products such as:
Diosmectit
Pharmacological property:
The medicine of natural origin possessing protective effect regarding mucous membrane of the intestines and severe absorbing properties. Diosmectit, being the stabilizer of the mucous barrier, penetrates the mucus and increases the duration of life, forming physical barrier that protects the mucous membrane of the digestive tract against negative effects of H+ ions, intestinal microorganisms, their toxins (hazardous waste products). In addition, the drug has good coating ability.
Indications for use:
Symptomatic (facilitating the patient's condition without significant impact on the cause of the disease) treatment of pain associated with diseases of esophagus, stomach, duodenum; intestinal colic; acute and chronic diarrhea, especially in children.
Side effects:
Constipation may occur.
Contraindications:
Intestinal obstruction.
Attention!
Before using the drug Diosmectit you should consult with your doctor. This instruction for use is given in free translation and is intended for information only. For more information, please contact the manufacturer annotations.
Diclofen plus
Pharmacological property:
Anti-inflammatory, antipyretic, analgesic. Inhibits cyclooxygenase and inhibits PG biosynthesis.
Indications:
Inflammatory and degenerative joint diseases: rheumatism, rheumatoid arthritis, ankylosing spondylitis, osteoarthrosis and spondylarthritis; gout, extra-articular forms of rheumatism, dysmenorrhea, inflammatory syndrome.
Contraindications:
Hypersensitivity, including that in the history, peptic ulcer disease, pregnancy (Ist trimester).
Side effects:
Epigastric pain, belching, vomiting, diarrhea, headaches, slight dizziness, allergic skin reactions; when using candles - burning sensation in the rectum and tenesmus.
Precautions:
At long-term use it is necessary to regularly monitor the cellular composition of the blood. For the time of treatment breastfeeding should be stopped.